Live Breaking News & Updates on Carole Nuechterlein

Stay updated with breaking news from Carole nuechterlein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Enthera Pharmaceuticals Extends Series A Financing, Raising a Total Of €35m


Enthera Pharmaceuticals Extends Series A Financing, Raising a Total Of €35m
Funds to be used to advance restorative therapy for type 1 diabetes and inflammatory bowel disease
Largest international VC-backed Series A financing round for a biotech in Italy to date and first ever venture investment in an Italian company by both AbbVie Ventures and Roche Venture Fund
Proceeds to be used for clinical proof-of-concept for lead product Ent001 (IGFBP3/TMEM219 inhibitor) for type 1 diabetes, gastrointestinal diseases and progress pipeline assets
Enthera Pharmaceuticals ( Enthera ), a biotech company developing disease-modifying biologics to transform the therapeutic paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way, today announces the final closing of its Series A financing, with a total financing of €35m. ....

France General , City Of , United Kingdom , Enthera Srl , Banca Profilo , Arepo Fiduciaria , Carole Nuechterlein , Silvano Spinelli , Francesca Daddio , Giovanni Amabile , Paolo Fiorina , Gabriella Camboni , Rd Fund , Life Sciences , Enthera Pharmaceuticals , Roche Venture Fund , Head Roche Venture Fund , Sofinnova Partners , Abbvie Ventures , Indaco Venture Partners , Enthera Board , Prof Paolo Fiorina , Sofinnova Partners Abbvie Ventures , Roche Venture , South San Francisco , Asia The ,